Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
Recruiting · NCT07243639 · Interventional (participants receive a specific treatment) · Lead sponsor: Showa Inan General Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Etrasimod administration
What this trial is about
Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with active ulcerative colitis
Exclusion criteria
- the presence of acute or chronic renal failure, chronic heart disease, pulmonary infection, liver cirrhosis, colorectal cancer, autoimmune disease, and infectious disease
Where it is running
1 location listed.
- Showa Inan General Hospital - Komagane, Nagano, Japan